Nuclear factor-κB is upregulated in colorectal cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
1976 • 225,752 citations
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
1976 • 200,127 citations
Cancer statistics, 2000
2000 • 3,907 citations
NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
1998 • 2,698 citations
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
2001 • 1,427 citations
How NF-κB is activated: the role of the IκB kinase (IKK) complex
1999 • 1,133 citations
Signal transduction through NF-κB
1998 • 1,103 citations
Caspases: the proteases of the apoptotic pathway
1998 • 1,048 citations
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
1997 • 824 citations
Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
1997 • 780 citations
Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
1995 • 741 citations
DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1
1998 • 726 citations
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
1997 • 717 citations
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
1999 • 640 citations
Transcriptional Cross Talk between NF-κB and p53
1999 • 590 citations
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
2000 • 324 citations
Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells
1999 • 292 citations
NF-κB to the rescue: RELs, apoptosis and cellular transformation
1999 • 276 citations
Activation of NF-κB by Antineoplastic Agents
1997 • 271 citations
Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
1999 • 265 citations
Inhibition of Nuclear Factor κB Activation Attenuates Apoptosis Resistance in Lymphoid Cells
1998 • 225 citations
Proteasome-Dependent Regulation of p21WAF1/CIP1Expression
1996 • 223 citations
NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells
1997 • 191 citations
Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
2000 • 160 citations
Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
2000 • 159 citations
The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies
1999 • 129 citations
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
1999 • 113 citations
Inhibition of NF-κB sensitizes non–small cell lung cancer cells to chemotherapy-induced apoptosis
2000 • 109 citations
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs.
1999 • 88 citations
Caspase-3–Dependent Organ Apoptosis Early After Burn Injury
1999 • 67 citations
Introduction: Gemcitabine - Status of preclinical studies and perspectives for future clinical applications of this novel nucleoside analog
1995 • 16 citations
Apoptosis in cancer: therapeutic implications.
2000 • 14 citations